Mouse fetal period ovary in-vitro culture model as well as construction method and application thereof
By using culture medium carrying lentiviral vectors of the target gene, the microdrop method and complete medium were used to alternately process the fetal ovaries of mice, a simple and easy-to-use in vitro culture model of the fetal ovaries in mice was constructed, and the microinjection method was solved The difficult problem has achieved effective in vitro culture of overexpression or interference of ovarian genes in the fetal stage of mice.
Patent Information
- Application Number
- CN202411237315.8
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-09-04
- Publication Date
- 2024-11-29
AI Technical Summary
The existing mouse fetal ovarian gene overexpression or interference in vitro culture models mainly rely on microinjection method, which is technically difficult, difficult to operate, and lacks a simple and easy construction method.
After the mouse fetal ovaries were initially cultured by microdroplet method using culture medium carrying the lentiviral vector of the target gene, the mouse fetal ovaries were further cultured by using complete culture medium to construct an in vitro culture model for fetal ovaries.
A mouse fetal ovarian in vitro culture model was successfully constructed, which is simpler and easier to perform than the complex microinjection method, and has no significant differences, achieving in vitro culture of overexpression or interference of target genes.
Smart Images

Figure CN119040398A_ABST
Abstract
Description
Technical Field
[0001] The present invention relates to the technical field of reproductive medicine, and in particular to an in vitro culture model of mouse fetal ovaries and a construction method and application thereof. Background Art
[0002] The ovary is an important reproductive organ for women and female mammals. Follicles at different stages of development are the main structural and functional units of the ovary, which are very important for ovulation and the secretion of hormones that maintain secondary sexual characteristics and early pregnancy. Generally speaking, the formation of primordial follicles occurs during the fetal period or before and after birth, and the number of primordial follicles formed determines the fertility of women and female mammals throughout their lives.
[0003] Mouse fetal ovaries are cheap and easy to obtain, and are good materials for studying the development of primordial follicles and other levels of follicles. The functions and in-depth mechanism studies of genes related to follicular development can be achieved by constructing an in vitro culture model of overexpression or interference of target genes in fetal ovaries. At present, the construction of an in vitro culture model of overexpression or interference of target genes in mouse fetal ovaries is mainly achieved by microinjection, which is technically difficult and difficult to operate. Therefore, it is urgent to develop a simple and easy in vitro culture model of overexpression or interference of target genes in mouse fetal ovaries. Summary of the invention
[0004] The purpose of the present invention is to provide a simple and easy in vitro culture model of mouse fetal ovary, and in particular to an in vitro culture model of mouse fetal ovary and a construction method and application thereof.
[0005] In order to achieve the above-mentioned object of the invention, the present invention provides the following technical solutions:
[0006] The present invention provides a method for constructing an in vitro culture model of mouse fetal ovaries, comprising the following steps:
[0007] (1) Cultivating mouse fetal ovaries in microdroplets for 8 to 16 hours to obtain primary cultured mouse fetal ovaries;
[0008] (2) The primary cultured mouse fetal ovaries are cultured in complete culture medium to obtain a mouse fetal ovary in vitro culture model.
[0009] Preferably, the droplets are prepared from a culture medium carrying a target gene vector;
[0010] The vector carrying the target gene is a lentiviral vector carrying the target gene;
[0011] The lentiviral vector carrying the target gene is a lentiviral overexpression vector carrying the target gene or a lentiviral interference vector carrying the target gene.
[0012] Preferably, the culture medium is DMEM / F12 culture medium.
[0013] Preferably, the titer of the lentivirus in the culture medium carrying the target gene vector is 1×10 8 ~3×10 8 TU / mL.
[0014] Preferably, in step (1), the culture temperature is 35-39°C.
[0015] Preferably, in step (2), the complete culture medium is DMEM / F12 culture medium.
[0016] Preferably, in step (2), the culture temperature is 35-39°C.
[0017] The present invention also provides application of the construction method in constructing an in vitro culture model of mouse fetal ovaries.
[0018] The present invention also provides a mouse fetal ovary in vitro culture model constructed by the construction method.
[0019] Beneficial effects of the present invention:
[0020] The present invention provides a method for constructing an in vitro culture model of mouse fetal ovaries, wherein the method comprises using a culture medium containing a certain titer of a target gene lentivirus overexpression vector or a lentivirus interference vector, culturing the mouse fetal ovaries for a certain period of time by a microdrop method, and then using a complete culture medium for culturing to obtain an in vitro culture model of mouse fetal ovaries. The construction method of the present invention can successfully construct an in vitro culture model of mouse fetal ovaries, and the construction method is simpler and easier to implement than the complex microinjection method. BRIEF DESCRIPTION OF THE DRAWINGS
[0021] Figure 1 The green fluorescence expression of the in vitro culture model of mouse fetal ovarian CYP51A1 overexpression, wherein Figure A is the green fluorescence expression of the in vitro culture model of mouse fetal ovarian CYP51A1 overexpression constructed in Example 1, and Figure B is the green fluorescence expression of the in vitro culture model of mouse fetal ovarian CYP51A1 overexpression constructed in Comparative Example 1;
[0022] Figure 2 Figure 2 is the green fluorescence expression of the mouse fetal ovarian circ-018161 interfering in vitro culture model, wherein Figure A is the green fluorescence expression of the mouse fetal ovarian circ-018161 interfering in vitro culture model constructed in Example 2, and Figure B is the green fluorescence expression of the mouse fetal ovarian circ-018161 interfering in vitro culture model constructed in Example 2. DETAILED DESCRIPTION
[0023] The present invention provides a method for constructing an in vitro culture model of mouse fetal ovaries, comprising the following steps:
[0024] (1) Cultivating mouse fetal ovaries in microdroplets for 8 to 16 hours to obtain primary cultured mouse fetal ovaries;
[0025] (2) The primary cultured mouse fetal ovaries are cultured in complete culture medium to obtain a mouse fetal ovary in vitro culture model.
[0026] In the present invention, the droplets are prepared from a culture medium carrying a target gene vector;
[0027] The vector carrying the target gene is a lentiviral vector carrying the target gene;
[0028] The lentiviral vector carrying the target gene is a lentiviral overexpression vector carrying the target gene or a lentiviral interference vector carrying the target gene.
[0029] In the present invention, the culture medium is DMEM / F12 culture medium.
[0030] In the present invention, the titer of the lentivirus in the culture medium carrying the target gene vector is 1×10 8 ~3×10 8 TU / mL, preferably 2×10 8 TU / mL.
[0031] In the present invention, the target gene in the vector carrying the target gene is CYP51A1 (NCBI accession number: NM_020010.2) or circ-018161.
[0032] The circ-018161 is a circular RNA obtained by sequencing in the ovary of the mouse embryonic stage, and its sequence is shown in SEQ ID NO: 1;
[0033] SEQ ID NO: 1 is ATATCCGTGGAATCCAGGAATTTTTGGACAAAGTATCCCAGCAGGGAATGGATGTTGCCCTTCAAAAGGTGGAAAACAACATCAACAAATGATCACCACACTCTTTGACACCATGAGGATAGAGGAGTTGAATCGCTATCGAGACACTCTTAGAAGAGCCATCCTTGTCATGAATCCTGCCACAGCCAAATCCTTCATAAGTGAG.
[0034] In the present invention, in step (1), before culturing, the droplets need to be covered with mineral oil and placed in a carbon dioxide incubator for equilibration for 2 to 4 hours, preferably 3 hours;
[0035] In the carbon dioxide incubator, the concentration of carbon dioxide is 4-6%, preferably 5%;
[0036] Before culture, the mouse fetal ovaries need to be washed 2 to 4 times, preferably 3 times, with balanced complete culture medium.
[0037] In the present invention, 3 to 5 mouse fetal ovaries are cultured in each microdroplet, preferably 4.
[0038] In the present invention, in step (1), the culture temperature is 35-39°C, preferably 36-38°C, and more preferably 37°C; the culture time is preferably 10-14h, and more preferably 12h.
[0039] In the present invention, in step (2), the complete culture medium is DMEM / F12 culture medium.
[0040] In the present invention, in step (2), before culturing the primary cultured mouse fetal ovaries in a complete culture medium, the complete culture medium needs to be placed in a carbon dioxide incubator for equilibration for 2 to 4 hours, preferably 3 hours;
[0041] In the carbon dioxide incubator, the concentration of carbon dioxide is 4-6%, preferably 5%;
[0042] The initial culture of mouse fetal ovaries needs to be washed 2 to 4 times, preferably 3 times, with balanced complete culture medium.
[0043] In the present invention, in step (2), the culture temperature is 35-39°C, preferably 36-38°C, and more preferably 37°C.
[0044] In the present invention, in step (2), during the culture process, half of the medium is replaced once every 48 hours.
[0045] The present invention also provides application of the construction method in constructing an in vitro culture model of mouse fetal ovaries.
[0046] The present invention also provides a mouse fetal ovary in vitro culture model constructed by the construction method.
[0047] The technical solutions provided by the present invention are described in detail below in conjunction with the embodiments, but they should not be construed as limiting the protection scope of the present invention.
[0048] Example 1 Construction of an in vitro culture model of ovarian CYP51A1 overexpression in mice during the fetal period
[0049] Materials preparation:
[0050] a. Collection of fetal ovaries of mice: 9-week-old sexually mature and naturally estrus ICR female mice (purchased from Beijing Weitong Lihua Experimental Animal Technology Co., Ltd.) were selected and caged with adult ICR male mice (purchased from Beijing Weitong Lihua Experimental Animal Technology Co., Ltd.) at a ratio of 1:1. The vaginal plug was checked the next morning, and the mice with plugs were raised in separate cages; female mice at 17.5 days of pregnancy were killed by cervical dislocation, and the fetuses in the uterus were collected by laparotomy using sterile scissors and forceps and placed in a 4°C sterile PBS solution. Subsequently, based on the morphological differences between male and female gonads, the ovaries of the female fetuses were collected using a sterile dissecting needle and a 1 mL syringe under a stereomicroscope. After carefully removing the attachments around the ovaries, the fetal ovaries of mice were obtained;
[0051] b. Balanced droplets: DMEM / F12 medium was used to dilute the ovarian CYP51A1 lentiviral overexpression vector (constructed by Shanghai GeneCare Gene Medical Technology Co., Ltd.) carrying green fluorescent protein to obtain a DMEM / F12 medium containing the ovarian CYP51A1 lentiviral overexpression vector. The lentiviral titer in the medium was 2×10 8 TU / mL, the culture medium was made into four 100 μL microdroplets in a 35 mm culture dish, the microdroplets were covered with mineral oil and placed in a carbon dioxide incubator at 37°C and 5% carbon dioxide concentration for 4 h to obtain equilibrated microdroplets;
[0052] c. Balanced DMEM / F12 medium: The DMEM / F12 medium was placed in a carbon dioxide incubator at 37°C and a carbon dioxide concentration of 5% for 4 hours to obtain a balanced DMEM / F12 medium;
[0053] Construction of an in vitro culture model of CYP51A1 overexpression in the mouse fetal ovary:
[0054] (1) After washing the mouse fetal ovaries three times with balanced DMEM / F12 medium, the ovaries were transferred to balanced microdroplets, with four ovaries placed in each balanced microdroplet, and cultured in a carbon dioxide incubator at 37° C. and a carbon dioxide concentration of 5% for 10 hours to obtain primary cultured mouse fetal ovaries;
[0055] (2) The primary cultured mouse fetal ovaries were washed three times with balanced DMEM / F12 medium and transferred to balanced DMEM / F12 medium for culture (cultured in a 4-well plate, with each well containing 1.5 mL of DMEM / F12 complete medium) to obtain an in vitro culture model of mouse fetal ovarian CYP51A1 overexpression; the medium was replaced by half every 48 hours and cultured for 4 days. The mouse fetal ovarian CYP51A1 overexpression in vitro culture model was detected every day using an inverted fluorescence microscope. The detection results of green fluorescence expression were as follows: Figure 1 As shown in A.
[0056] Comparative Example 1 Construction of an in vitro culture model of ovarian CYP51A1 overexpression in mice during the fetal period by microinjection
[0057] Materials preparation:
[0058] a. Mouse fetal ovaries were collected and balanced with DMEM / F12 medium as in Example 1;
[0059] b. CYP51A1 lentiviral overexpression vector dilution: The ovarian CYP51A1 lentiviral overexpression vector with green fluorescent protein (constructed by Shanghai GeneCare Gene Medical Technology Co., Ltd.) was diluted with DMEM / F12 medium to obtain DMEM / F12 medium containing the ovarian CYP51A1 lentiviral overexpression vector, i.e., the CYP51A1 lentiviral overexpression vector dilution. The lentiviral titer in the medium was 2×10 8 TU / mL,
[0060] Construction of an in vitro culture model of CYP51A1 overexpression in the mouse fetal ovary:
[0061] The mouse fetal ovaries were washed three times with balanced DMEM / F12 medium, and then transferred to a 35 mm culture dish containing 1.5 mL of balanced DMEM / F12 medium. The dish was placed under a stereo microscope, and one end of the ovary was fixed with ophthalmic forceps. 5 μL of CYP51A1 lentiviral overexpression vector dilution was slowly injected into the opposite side of the fixed end of the ovary with a microinjection needle. The same amount of CYP51A1 lentiviral overexpression vector dilution was also injected into the other end of the ovary in the same way. After the injection, the dish was transferred to balanced DMEM / F12 medium for culture (cultured in a 4-well plate, each well containing 1.5 mL of DMEM / F12 complete medium) to obtain an in vitro culture model of mouse fetal ovarian CYP51A1 overexpression. The medium was replaced by half every 48 hours, and the culture was continued for 4 days. The mouse fetal ovarian CYP51A1 overexpression in vitro culture model was detected every day by an inverted fluorescence microscope. The detection results of green fluorescence expression are shown in Figure 2. Figure 1 As shown in B.
[0062] from Figure 1 It can be seen that the construction method described in Example 1 was successfully used to construct an in vitro culture model of mouse fetal ovarian CYP51A1 overexpression, which had no significant difference compared with the in vitro culture model of mouse fetal ovarian CYP51A1 overexpression constructed by the complex microinjection method, and the construction method described in Example 1 was simpler and easier to perform than the microinjection method.
[0063] Example 2 Construction of an in vitro culture model of circ-018161 interference in the ovary of mice during the fetal period
[0064] Materials preparation:
[0065] a. Mouse fetal ovaries were collected and balanced with DMEM / F12 medium as in Example 1;
[0066] b. Balanced droplets: DMEM / F12 medium was used to dilute the circ-018161 lentiviral interference vector (constructed by Shanghai GeneCare Gene Medical Technology Co., Ltd.) to obtain DMEM / F12 medium containing the circ-018161 lentiviral interference vector. The titer of the lentivirus in the medium was 2×10 8 TU / mL, the culture medium was made into four 100 μL microdroplets in a 35 mm culture dish, the microdroplets were covered with mineral oil and placed in a carbon dioxide incubator at 37°C and 5% carbon dioxide concentration for 4 h to obtain equilibrated microdroplets;
[0067] Construction of in vitro culture model of circ-018161 interference in mouse fetal ovary:
[0068] (1) After washing the mouse fetal ovaries three times with balanced DMEM / F12 medium, the ovaries were transferred to balanced microdroplets, with four ovaries placed in each balanced microdroplet, and cultured in a carbon dioxide incubator at 37° C. and a carbon dioxide concentration of 5% for 10 hours to obtain primary cultured mouse fetal ovaries;
[0069] (2) The primary cultured mouse fetal ovaries were washed three times with balanced DMEM / F12 medium and transferred to balanced DMEM / F12 medium for culture (cultured in a 4-well plate, with each well containing 1.5 mL of DMEM / F12 complete medium) to obtain an in vitro culture model of mouse fetal ovarian circ-018161 interference; the medium was replaced by half every 48 hours and cultured for 3 days. The mouse fetal ovarian circ-018161 interference in vitro culture model was detected every day using an inverted fluorescence microscope. The detection results of green fluorescence expression are shown in Figure 2. Figure 2 As shown in A.
[0070] Comparative Example 2 Construction of in vitro culture model of circ-018161 interference in mouse fetal ovary by microinjection
[0071] Materials preparation:
[0072] a. Mouse fetal ovaries were collected and balanced with DMEM / F12 medium as in Example 1;
[0073] b. circ-018161 interference vector dilution: The circ-018161 lentiviral interference vector (constructed by Shanghai GeneCare Gene Medical Technology Co., Ltd.) was diluted with DMEM / F12 medium to obtain DMEM / F12 medium containing the circ-018161 lentiviral interference vector, i.e., the circ-018161 interference vector dilution. The titer of the lentivirus in the medium was 2×10 8 TU / mL,
[0074] Construction of an in vitro culture model of CYP51A1 overexpression in the mouse fetal ovary:
[0075] The mouse fetal ovaries were washed three times with balanced DMEM / F12 medium, and then transferred to a 35 mm culture dish containing 1.5 mL of balanced DMEM / F12 medium. The dish was placed under a stereo microscope, and one end of the ovary was fixed with ophthalmic forceps. 5 μL of circ-018161 interference vector dilution was slowly injected into the opposite side of the fixed end of the ovary with a microinjection needle. The same amount of circ-018161 interference vector dilution was also injected into the other end of the ovary in the same way. After the injection, the dish was transferred to balanced DMEM / F12 medium for culture (cultured in a 4-well plate, each well containing 1.5 mL of DMEM / F12 complete medium) to obtain a mouse fetal ovarian circ-018161 interference in vitro culture model. The medium was replaced by half every 48 hours, and the culture was continued for 4 days. The mouse fetal ovarian circ-018161 interference in vitro culture model was detected every day by an inverted fluorescence microscope. The detection results of green fluorescence expression are shown in Figure 2. Figure 2 As shown in B.
[0076] from Figure 2 It can be seen that the construction method described in Example 2 was successfully used to construct the mouse fetal ovarian circ-018161 interference in vitro culture model, which had no significant difference compared with the mouse fetal ovarian circ-018161 interference in vitro culture model constructed by the complex microinjection method, and the construction method described in Example 2 was simpler and easier to perform than the microinjection method.
[0077] As can be seen from the above embodiments, the present invention provides a mouse fetal ovarian in vitro culture model and its construction method and application. The construction method described in the present invention can successfully construct a mouse fetal ovarian in vitro culture model, and the construction method is simpler and easier to implement than the complex microinjection method.
[0078] The above is only a preferred embodiment of the present invention. It should be pointed out that for ordinary technicians in this technical field, several improvements and modifications can be made without departing from the principle of the present invention. These improvements and modifications should also be regarded as the scope of protection of the present invention.
Claims
1. A method for constructing an in vitro culture model of mouse fetal ovaries, characterized in that: The steps include: (1) Cultivating mouse fetal ovaries in microdroplets for 8 to 16 hours to obtain primary cultured mouse fetal ovaries; (2) The primary cultured mouse fetal ovaries are cultured in complete culture medium to obtain a mouse fetal ovary in vitro culture model.
2. The construction method according to claim 1, characterized in that: The microdroplets are prepared from a culture medium carrying a target gene vector; The vector carrying the target gene is a lentiviral vector carrying the target gene; The lentiviral vector carrying the target gene is a lentiviral overexpression vector carrying the target gene or a lentiviral interference vector carrying the target gene.
3. The construction method according to claim 2, characterized in that: The culture medium is DMEM / F12 culture medium.
4. The construction method according to claim 3, characterized in that: The titer of the lentivirus in the culture medium carrying the target gene vector is 1×10 8 ~3×10 8 TU / mL.
5. The construction method according to claim 4, characterized in that: In step (1), the culture temperature is 35-39°C.
6. The construction method according to claim 5, characterized in that: In step (2), the complete culture medium is DMEM / F12 culture medium.
7. The construction method according to claim 6, characterized in that: In step (2), the culture temperature is 35-39°C.
8. Use of the construction method according to any one of claims 1 to 7 in constructing an in vitro culture model of mouse fetal ovaries.
9. The mouse fetal ovary in vitro culture model constructed by the construction method according to any one of claims 1 to 7.
